TITLE:
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
Lurasidone 20 mg

SUMMARY:

      The purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a
      placebo and to haloperidol in patients with schizophrenia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 64 Years
Criteria:

        Inclusion criteria:

          -  The patient has a primary diagnosis of schizophrenia

          -  The patient has been hospitalized with acute or relapsing schizophrenia within 3
             weeks of screening

          -  The patient has had a duration of illness of at least one year.

          -  The patient has a BPRS score of at least 42 at baseline and a score of at least 4 in
             two or more items of the positive symptom subcluster on the PANSS

          -  The patient is able to remain off antipsychotic medication for a 4 day washout period

        Exclusion criteria:

          -  The patient has had psychiatric hospitalizations other than current hospitalizations
             within 1 month prior to screening.

          -  The patient is considered treatment resistant-Substance abuse-Prolactin level of >
             200 ng/mL at baseline

          -  Pregnancy
      
